A multi-institutional campaign to harness a newly recognized cellular defense against infection is being led by researchers at the School of Medicine. A $32 million grant from the National Institutes of Health is funding the collaborative, which could lead to drugs with unprecedented versatility in fighting different infections. Washington University’s Herbert W. Virgin IV, MD, PhD, is the principal investigator.
Karen Seibert, PhD, research professor of pathology and immunology and of genetics, helps scientists connect and collaborate. Seibert, who does so with a mixture of warmth, optimism, enthusiasm and humor, is the director of Genomic Pathology Services at Washington University, a groundbreaking service that simultaneously analyzes many different genes to help patients and their doctors identify the best treatment options.
The American Academy of Microbiology has named three Washington University faculty members as fellows: Herbert W. “Skip” Virgin, M.D., Ph.D., Himadri B. Pakrasi, Ph.D., and Michael Diamond, M.D., Ph.D.